Net profit of Piramal Pharma rose 350.00% to Rs 22.59 crore in the quarter ended September 2024 as against Rs 5.02 crore during the previous quarter ended September 2023. Sales rose 17.28% to Rs 2241.75 crore in the quarter ended September 2024 as against Rs 1911.38 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 2241.75 | 1911.38 | 17 |
| OPM % | 15.24 | 13.90 | - |
| PBDT | 312.34 | 224.07 | 39 |
| PBT | 120.12 | 39.56 | 204 |
| NP | 22.59 | 5.02 | 350 |